ArticleBMC infectious diseases2026
Mutations in sugar metabolism-related genes driving global drug-resistant Mycobacterium tuberculosis transmission revealed by whole-genome sequencing.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTuberculosis (TB) continues to represent a significant global health challenge, particularly due to the emergence of drug-resistant strains that hinder TB control initiatives. Elucidating the mechanisms underlying the proliferation of drug-resistant strains is essential for developing effective strategies to address this public health threat.
methodsWhole-genome sequencing was conducted on 13,525 Mycobacterium tuberculosis isolates. Genes associated with sugar metabolism were obtained from the National Center for Biotechnology Information (NCBI) Gene database. Analytical approaches, including Random Forests, Gradient Boosting Decision Trees, and Generalized Linear Mixed Models were used to identify mutation sites in sugar metabolism genes that contribute to transmission of Multidrug-Resistant Tuberculosis (MDR-TB).
resultsSignificant associations were identified between specific gene mutations and transmission clusters in MDR-TB. Notable mutations include Rv0650 (C113T, C316T), sugB C734A, epiA C43T, Rv151c C8G, Rv1520 (C138T, T618C, A649C), Rv2038c G282A, Rv2039c (G391T, T283G), Rv2040c G835C, Rv2316 C161G, and sugI C1268T. Additionally, mutations associated with MDR-TB transmission clusters, include Rv0650 C316T, Rv151c T809C, and Rv2039c C794T. Certain mutations, such as Rv0539 G588T and uspA G379C, were found to increase the risk of cross-regional transmission in MDR clades. The presence of Rv1512 (epiA, C462T) and Rv2038c T161G was associated with an increased therisk of developing MDR isolates compared to single drug resistant (SDR) isolates.
conclusionMutations in sugar metabolism genes significantly contribute to the global transmission of MDR-TB. Identifing these genetic determinants canguide targeted interventions to control drug-resistant strains and improve TB management. Further research is required to elucidate mechanism underlying mechanisms of transmission and resistance development. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.